We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Residual Tissue Repositories Suitable for MS-Based Proteomics

By LabMedica International staff writers
Posted on 12 Sep 2018
Print article
Image: The Q Exactive hybrid quadrupole-orbitrap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
Image: The Q Exactive hybrid quadrupole-orbitrap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
Mass spectrometry-based proteomics has become a powerful tool for the identification and quantification of proteins from a wide variety of biological specimens.

The majority of studies utilizing tissue samples have been carried out on prospectively collected fresh frozen or optimal cutting temperature (OCT) embedded specimens. However, such specimens are often difficult to obtain, in limited in supply, and clinical information and outcomes on patients are inherently delayed as compared to banked samples.

Scientists from the Pacific Northwest National Laboratory (Richland, WA, USA) and their colleagues analyzed 60 patient samples taken from the NCI's Surveillance, Epidemiology, and End Results (SEER) residual tissue repositories, which contain samples from more than 100,000 cancer patients, along with detailed demographic information, data on tumor characteristics, treatment, survival, and cause of death. The 60 samples ranged in their time of storage from seven to 32 years.

The team used 10-plex tandem mass tag (TMT) labeling and divided each sample into six fractions, each of which they then ran on a 100-minute nanoLC gradient upfront of analysis on a Q-Exactive Plus instrument. For phosphopeptide analysis, they used Immobilized Metal Affinity Chromatography (IMAC) enrichment. They found that all 60 samples provided sufficient material for proteome-wide protein expression analysis and 18 of the 60 samples provided enough material for phosphopeptide work.

The investigators identified and quantified a total of 8,582 proteins and 8,073 phosphopeptides across the SEER sample set, indicating that FFPE tissue is amenable to mass spec proteomics analysis. Protein identifications were reduced compared to the identifications possible in comparable optimal cutting temperature (OCT) compound-embedded specimens. Compared to OCT samples, peptide, protein, and phosphopeptide identifications were reduced by 50%, 20%, and 76%, respectively.

Karin D, Rodland, PhD, an expert in mass spectrometry and a senior author of the study, said, “There have been commercial kits available for 12 to 15 years for extracting proteins out of FFPE blocks, and on the face of it, the yields of protein from the FFPE blocks is not that bad. But with the mass spec technologies of 12 to 15 years ago, the rate of identification was very low. You just didn't get good [proteome] coverage out of FFPE blocks. And the assumption was that the formalin crosslinking was causing you to lose identifications. However, improvements in mass spec technology have provided instruments with higher sensitivity and better resolution that are capable of working with smaller amounts of sample.” The study was published on August 3, 2018, in the journal Clinical Proteomics.

Related Links:
Pacific Northwest National Laboratory

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.